Henrietta, NY — Turbett Surgical has appointed Jennifer Scalise-Mullett, J.D., as Vice President of Quality, Regulatory and Compliance.
In the role, Scalise-Mullett will oversee the company’s global regulatory affairs, quality assurance and compliance activities. She will also advise on regulatory and quality matters tied to business strategy, operations and the commercialization of Turbett Surgical’s multi-tray sterilization systems.
Scalise-Mullett brings more than 20 years of experience across the medical device, biotechnology and pharmaceutical industries. She has held leadership roles at Fresenius, Biogen Idec, McKesson and Boston Pharmaceuticals, which was recently acquired by GSK.
She has also guided medical technologies through U.S. Food and Drug Administration clearances and international regulatory processes. Scalise-Mullett holds a J.D. from Suffolk University Law School.
“Jennifer’s proven track record in medical device regulation and her commitment to quality excellence make her a perfect fit for our leadership team,” said Kevin Danahy, CEO of Turbett Surgical. “As we continue to innovate and disrupt the traditional instrument sterilization workflow, her guidance will ensure our products consistently meet and exceed the highest regulatory benchmarks.”
“I am thrilled to join Turbett Surgical at such a pivotal time in the company’s growth,” Scalise-Mullett said. “Turbett’s technology solves a critical bottleneck in the surgical workflow, directly impacting hospital efficiency and patient care. I look forward to collaborating with this talented team to provide strategic guidance on quality, regulatory and compliance initiatives that support business objectives, foster operational excellence and position the company for continued success.”
Turbett Surgical also thanked ALG Partners for its support during the executive search and recognized William Ford, President of ALG Partners, for his role in the process. (Source: IANS)
